Safety, pharmacokinetics, and preliminary assessment of efficacy of mecasermin (recombinant human IGF-1) for the treatment of Rett syndrome
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Safety, pharmacokinetics, and preliminary assessment of efficacy of mecasermin (recombinant human IGF-1) for the treatment of Rett syndrome
Authors
Keywords
-
Journal
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Volume 111, Issue 12, Pages 4596-4601
Publisher
Proceedings of the National Academy of Sciences
Online
2014-03-13
DOI
10.1073/pnas.1311141111
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Insulinotropic treatments exacerbate metabolic syndrome in mice lacking MeCP2 function
- (2013) Meagan R. Pitcher et al. HUMAN MOLECULAR GENETICS
- Morphological and functional reversal of phenotypes in a mouse model of Rett syndrome
- (2012) Lianne Robinson et al. BRAIN
- Pubertal trajectory in females with Rett syndrome: A population-based study
- (2012) Olivia Knight et al. BRAIN & DEVELOPMENT
- Peptide Mimetics of Neurotrophins and their Receptors
- (2012) S. D. Skaper CURRENT PHARMACEUTICAL DESIGN
- The Insulin-Like Growth Factors and Growth Disorders of Childhood
- (2012) Philippe F. Backeljauw et al. ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA
- Neurodevelopmental effects of insulin-like growth factor signaling
- (2012) John O’Kusky et al. FRONTIERS IN NEUROENDOCRINOLOGY
- Insulin-like growth factor 1 (IGF1) and its active peptide (1–3)IGF1 enhance the expression of synaptic markers in neuronal circuits through different cellular mechanisms
- (2012) Aiden P. Corvin et al. NEUROSCIENCE LETTERS
- Translational research
- (2011) Omar S. Khwaja et al. CURRENT OPINION IN PEDIATRICS
- Normal ranges of heart rate and respiratory rate in children from birth to 18 years of age: a systematic review of observational studies
- (2011) Susannah Fleming et al. LANCET
- Effects of Fluoxetine Treatment on Striatal Dopamine Transporter Binding and Cerebrospinal Fluid Insulin-Like Growth Factor-1 in Children with Autism
- (2011) I. Makkonen et al. NEUROPEDIATRICS
- The short-time structural plasticity of dendritic spines is altered in a model of Rett syndrome
- (2011) Silvia Landi et al. Scientific Reports
- Rett syndrome: Revised diagnostic criteria and nomenclature
- (2010) Jeffrey L. Neul et al. ANNALS OF NEUROLOGY
- Rett syndrome diagnostic criteria: Lessons from the Natural History Study
- (2010) Alan K. Percy et al. ANNALS OF NEUROLOGY
- Insulin-like growth factor-1 is associated with cognitive outcome in infantile spasms
- (2010) Raili S. Riikonen et al. EPILEPSIA
- A Wearable Sensor for Unobtrusive, Long-Term Assessment of Electrodermal Activity
- (2010) Ming-Zher Poh et al. IEEE TRANSACTIONS ON BIOMEDICAL ENGINEERING
- Clinical assessment of DSM-IV anxiety disorders in fragile X syndrome: prevalence and characterization
- (2010) Lisa Cordeiro et al. Journal of Neurodevelopmental Disorders
- Mecasermin (recombinant human insulin-like growth factor I)
- (2009) Arlan L. Rosenbloom ADVANCES IN THERAPY
- Partial reversal of Rett Syndrome-like symptoms in MeCP2 mutant mice
- (2009) Daniela Tropea et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started